person

Marcello B.

Country
Spain
Department
Endocrinology

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
10
Sites with multiple studies

Has run more than one trial at 10 of 12 partner sites.

Specializations

Metabolic Disorders

This investigator specializes in treating rare metabolic conditions, with particular focus on Ornithine Transcarbamylase Deficiency (OTC) and Propionic Acidemia. Their research extends to innovative therapeutic approaches for these inherited metabolic disorders.

  • OTC Deficiency Management
  • Propionic Acidemia Treatment
  • Metabolic Disease Interventions

The investigator's work encompasses early intervention strategies for neonatal and pediatric patients with metabolic disorders.

Mitochondrial Medicine

Primary research interests include mitochondrial disorders and cerebellar ataxias, with specialized focus on coenzyme Q-based treatments. The investigator explores therapeutic applications of ubiquinol for neurological manifestations of mitochondrial diseases.

  • Mitochondrial Disease Treatment
  • Cerebellar Ataxia Management
  • Coenzyme Q Research

Their work involves evaluating novel therapeutic approaches for patients with confirmed genetic diagnoses of mitochondrial conditions.

Methylmalonic Acidemia

Specialized research in Methylmalonic Acidemia (MMA), particularly focusing on cases related to methylmalonyl-coenzyme A mutase deficiency. The investigator studies innovative therapeutic approaches for treating this rare genetic condition.

  • MMA Treatment Development
  • Long-term Disease Management
  • Genetic Metabolic Disorders

Their research encompasses both acute intervention strategies and long-term therapeutic solutions for MMA patients.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.